• Single-Cell RNA Isoforms in Alzheimer’s Brain

  2026-10-08

  Shahnaee and colleagues combine single-nucleus profiling with PacBio Kinnex long-read sequencing to examine full-length RNA isoforms in post-mortem Alzheimer’s disease brain tissue. The study reveals extensive cell-type-specific isoform diversity, disease-associated transcript changes, and candidate signatures of RNA switching, while also showing why these observations require careful validation before they are interpreted as causal mechanisms.

• MEDUSA Reveals How Drug-Induced Death Changes

  2026-10-08

  Honeywell and colleagues introduce MEDUSA, a time-resolved modeling framework that separates cell growth from cell death in pooled functional genomic screens. Applied to DNA damage responses, the study finds that p53 loss can shift lethality from apoptosis toward a respiration-dependent nonapoptotic mechanism, refining how genetic drug-sensitivity data should be interpreted.

• Synthetic DEFB1 mRNA and Cryptosporidiosis

  2026-10-07

  A recent Journal of Infectious Diseases study reports that synthetic DEFB1 mRNA increased β-defensin 1 protein in human intestinal cells and reduced Cryptosporidium parvum burden in vitro. The work illustrates how host-directed mRNA therapy can be evaluated through a combination of reporter-based delivery measurements, antimicrobial-peptide quantification, infection assays, and cell-health analyses.

• ARCA EGFP mRNA: Evidence and Limits

  2026-10-07

  ARCA EGFP mRNA is a direct-detection reporter for fluorescence-based assessment of delivery and mammalian cell gene expression. The product dossier supports defined transcript specifications and a supplier-reported HEK293T benchmark, but it does not independently establish performance across cell types, instruments, or delivery systems.

• HotStart Universal 2X Green qPCR Mix Overview

  2026-10-06

  A concise, source-limited overview of APExBIO’s HotStart™ Universal 2X Green qPCR Master Mix, SKU K1170. No matched paper evidence or independent performance validation was available for this product.

• Pseudo-UTP and Pseudouridine in mRNA Research

  2026-10-06

  Pseudo-modified uridine triphosphate is relevant to mRNA research because pseudouridine-containing transcripts have been associated with improved protein expression in some experimental systems. The supplied mouse study supports a role for modified nucleotides in an mRNA vaccine context, while also showing why findings should not be generalized automatically to human vaccines, gene therapy, or every RNA design.

• ABT-199 (Venetoclax) in T-ALL Research

  2026-10-05

  ABT-199, also known as Venetoclax, is a selective BCL-2 inhibitor relevant to studies of mitochondrial apoptosis and therapy resistance. This overview examines how the IL-7R/JAK/STAT5/BCL-2 axis was linked to glucocorticoid resistance in T-cell acute lymphoblastic leukemia, what ABT-199 can conceptually help investigate, and where evidence from a primary T-ALL study should not be generalized to other malignancies.

• Fosinopril Sodium: Evidence for Model Interpretation

  2026-10-05

  Fosinopril sodium is an ACE inhibitor with distinctive prodrug activation and dual elimination features. This article explains how those properties should shape interpretation of hypertension research, renal hemodynamics modulation, and cardiovascular disease models without confusing mechanistic evidence with outcomes from unrelated clinical trials.

• Biodegradable Polyesters for VEGF mRNA Delivery

  2026-10-04

  A 2026 Chemical Engineering Journal study reports three-armed biodegradable polyesters designed to mimic ionizable cationic lipid behavior while reducing concerns associated with persistent lipid materials. In preclinical models of critical limb ischemia, arginine-functionalized polyester nanoparticles improved VEGF mRNA delivery and combined transfection activity with reported reactive oxygen species scavenging and nitric oxide release.

• SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis

  2026-10-03

  A 2023 study links increased SMYD2 activity with cisplatin-induced renal fibrosis and inflammation, using AZ505 and LLY-507 as pharmacological probes. The findings support SMYD2 as a mechanistically relevant regulator of fibrotic, inflammatory, and epithelial-state changes, while remaining preclinical and model-specific.

• Bile Acid Subtypes Reveal CRC Immune Dysfunction Markers

  2026-10-01

  Feng et al. integrated bile acid metabolism with transcriptomic subtyping to distinguish colorectal cancer groups with different survival and immune-infiltration profiles. The study highlights CLCA1, UGT2A3, and ZG16 as reproducible candidate markers, while showing that their association with immune-treatment response remains hypothesis-generating rather than clinically established.

• ARCA EGFP mRNA: Reporter Control Guide

  2026-10-01

  ARCA EGFP mRNA is an enhanced green fluorescent protein mRNA for direct, fluorescence-based assessment of mammalian-cell transfection and protein expression. Its ARCA cap, approximately 100-nucleotide poly(A) tail, defined formulation, and reported performance in HEK293T cells support reproducible delivery benchmarking.

• KU-55933 ATM Kinase Inhibitor Workflow

  2026-09-30

  Build reproducible ATM signaling experiments with KU-55933 by combining selective pathway inhibition, phospho-Akt readouts, cell-cycle analysis, and metabolic phenotyping. A personalized iPSC screening framework from an ultrarare-disease study adds a practical model for matching genotype, controls, and orthogonal endpoints before expanding into cancer research.

• Gramine, CUL3–MTDH, and Ferroptosis in TNBC

  2026-09-30

  A 2026 study identifies Gramine as a selective suppressor of triple-negative breast cancer through a CUL3–MTDH ubiquitination mechanism that activates ferroptosis. Its combination of target-engagement assays, genetic perturbation, rescue experiments, and tumor models provides a mechanistic framework for studying this ferroptosis inducer in cancer biology research.

• ICG001: Reframing β-Catenin in Fibrosis

  2026-09-29

  The 2026 biliary atresia study positions MMP7-driven E-cadherin loss and β-catenin nuclear translocation as a mechanistic route to liver fibrosis. This article explains how ICG001, a selective Wnt/β-catenin pathway inhibitor, can test whether CBP-dependent β-catenin transcription is a functionally necessary downstream node in EMT and fibrosis, while also defining practical controls, translational boundaries, and opportunities across oncology and regenerative disease models.

8698 records 1/580 page Next 12345 下5页 Last page